NutriStack
Berberine and Semaglutide, a caution.
Both semaglutide and berberine lower blood glucose through complementary mechanisms, creating a significant risk of hypoglycemia when combined. Semaglutide stimulates glucose-dependent insulin secretion via GLP-1 receptor activation, while berberine activates AMPK and has been shown to increase endogenous GLP-1 secretion from intestinal L-cells. The additive glucose-lowering effect may be clinically dangerous, particularly in patients also taking insulin or sulfonylureas.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Berberine and Semaglutide
- Pair type
- Caution
- Evidence (highest tier)
- Moderate
- Source citations
- 2 sources
- Stack Score effect
- −5 to your Stack Score (per scored caution row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Caution · Moderate evidence
Caution
What is happening. Both semaglutide and berberine lower blood glucose through complementary mechanisms, creating a significant risk of hypoglycemia when combined. Semaglutide stimulates glucose-dependent insulin secretion via GLP-1 receptor activation, while berberine activates AMPK and has been shown to increase endogenous GLP-1 secretion from intestinal L-cells. The additive glucose-lowering effect may be clinically dangerous, particularly in patients also taking insulin or sulfonylureas.
Mechanism. Semaglutide activates GLP-1 receptors, enhancing glucose-dependent insulin secretion and suppressing glucagon. Berberine activates AMPK, improving insulin sensitivity, increasing glucose uptake, and stimulating endogenous GLP-1 secretion from intestinal L-cells. The combined glucose-lowering effect through multiple overlapping pathways amplifies hypoglycemia risk.
Recommendation. Do not add berberine to semaglutide therapy without prescriber supervision. If using both, implement frequent blood glucose monitoring (at least 4 times daily initially). Be alert for hypoglycemia symptoms: shakiness, sweating, confusion, rapid heartbeat. Carry fast-acting glucose at all times.
Sources (2)
- Yu Y et al. Berberine-induced glucagon-like peptide-1 and its mechanism for controlling type 2 diabetes mellitus: a comprehensive pathway review. Front Pharmacol. 2023;14:1265738. PMID 37921026
- Asbaghi O, Ghanbari N, Shekari M et al.. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials.. Clinical Nutrition ESPEN. 2020. PMID 32690176
Stack Score
How this pair moves the number.
Effect on the composite score
If both Berberine and Semaglutide are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.